Notably, PLK1 was highly expressed in the prostate tumors compared to the adjacent tissues, and its elevated expression correlated with poor overall survival (OS) and disease‐free survival (DFS) in various cohorts of prostate cancer patients (Figure 6B,C; Figure S6, Supporting Information). Here, PLK1 is linked to prostate carcinoma.